TESTOSTERONOLOGIST Trademark

Trademark Overview

On Friday, April 26, 2024, a trademark application was filed for TESTOSTERONOLOGIST with the United States Patent and Trademark Office. The USPTO has given the TESTOSTERONOLOGIST trademark a serial number of 98520851. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Tuesday, October 21, 2025. This trademark is owned by Anabolic Doc, Inc.. The TESTOSTERONOLOGIST trademark is filed in the category with the following description:

Medical services, namely, testosterone replacement therapy, treatment of hypertension, anabolic steroid induced hypogonadism, anabolic recovery medicine, pre-diabetes, androgen induced erythrocytosis, diabetes, hypercholesterolemia, cardiovascular disease, erectile dysfunction, and sexual dysfunction provided by doctors
testosteronologist

General Information

Serial Number98520851
Word MarkTESTOSTERONOLOGIST
Filing DateFriday, April 26, 2024
Status680 - APPROVED FOR PUBLICATION
Status DateTuesday, October 21, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Certification Mark StatementThe certification mark, as used by persons authorized by the certifier, certifies that the services provided are performed by a person who has met the standards and requirements established by the certifier with respect to experience, educational requirements, and passage of examinations given by the certifier regarding medical services in the field of treating patients in need of, suffering, or recovering from testosterone replacement therapy, hypertension, anabolic steroid induced hypogonadism, anabolic recovery medicine, pre-diabetes, androgen induced erythrocytosis, diabetes, hypercholesterolemia, cardiovascular disease, erectile dysfunction, and sexual dysfunction
Goods and ServicesMedical services, namely, testosterone replacement therapy, treatment of hypertension, anabolic steroid induced hypogonadism, anabolic recovery medicine, pre-diabetes, androgen induced erythrocytosis, diabetes, hypercholesterolemia, cardiovascular disease, erectile dysfunction, and sexual dysfunction provided by doctors

Classification Information

International ClassB -
US Class CodesB
Class Status Code6 - Active
Class Status DateFriday, April 26, 2024
Primary CodeB
First Use Anywhere DateTuesday, June 11, 2024
First Use In Commerce DateTuesday, June 11, 2024

Trademark Owner History

Party NameAnabolic Doc, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFort Lauderdale, FL 33308

Trademark Events

Event DateEvent Description
Friday, April 26, 2024NEW APPLICATION ENTERED
Sunday, October 20, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 12, 2024ASSIGNED TO EXAMINER
Thursday, November 14, 2024NON-FINAL ACTION WRITTEN
Thursday, November 14, 2024NON-FINAL ACTION E-MAILED
Thursday, November 14, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 17, 2025TEAS PETITION TO REVIVE RECEIVED
Monday, February 17, 2025PETITION TO REVIVE-GRANTED
Monday, February 17, 2025NOTICE OF REVIVAL - E-MAILED
Monday, February 17, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 25, 2025ASSIGNED TO LIE
Tuesday, February 25, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 25, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 17, 2025ASSIGNED TO EXAMINER
Monday, April 14, 2025NON-FINAL ACTION WRITTEN
Monday, April 14, 2025NON-FINAL ACTION E-MAILED
Monday, April 14, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 6, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 6, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 6, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 14, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 4, 2025WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, June 3, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 3, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 3, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 20, 2025PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, August 20, 2025NON-FINAL ACTION WRITTEN
Wednesday, August 20, 2025NON-FINAL ACTION E-MAILED
Wednesday, August 20, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 23, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 23, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 23, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 24, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 24, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 24, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 24, 2025TEAS AMENDMENT OF USE RECEIVED
Wednesday, September 24, 2025USE AMENDMENT FILED
Wednesday, September 24, 2025AMENDMENT TO USE PROCESSING COMPLETE
Tuesday, October 21, 2025USE AMENDMENT ACCEPTED
Tuesday, October 21, 2025APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

testosteronologist dysfunction diabetes anabolic induced androgen hypercholesterolemia erythrocytosis disease doctors provided